Phase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host disease.

Authors

Lia Perez
Hugo Fernandez
Pedro Horna
Marcie Riches
Frederick Locke
Teresa Field
John Powers
Eva Sahakian
Alejandro Villagra, George Washington University
Asmita Mishra
Brian Betts
Mohamed Kharfan-Dabaja
Francisca Beato
Leonel Ochoa-Bayona
Joseph Pidala
Claudio Anasetti

Document Type

Journal Article

Publication Date

11-1-2018

Journal

Bone marrow transplantation

Volume

53

Issue

11

Inclusive Pages

1434-1444

DOI

10.1038/s41409-018-0163-z

Keywords

Acute Disease; Female; Glucocorticoids; Graft vs Host Disease; Histone Deacetylase Inhibitors; Humans; Male; Middle Aged; Panobinostat

Comments

Epub 2018 Apr 18

APA Citation

Perez, L., Fernandez, H., Horna, P., Riches, M., Locke, F., Field, T., Powers, J., Sahakian, E., Villagra, A., Mishra, A., Betts, B., Kharfan-Dabaja, M., Beato, F., Ochoa-Bayona, L., Pidala, J., & Anasetti, C. (2018). Phase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host disease.. Bone marrow transplantation, 53 (11). http://dx.doi.org/10.1038/s41409-018-0163-z

Peer Reviewed

1